The 10th annual Oncology Update was held online in 2024, and the recorded lectures are now available.
This virtual study day is for doctors and nurses, general practitioners, and pharmacists caring for people with cancer. Over the past 3 years, 144 people have attended.
Could not attend on the day? Register to access and watch the recordings. Delegates have previously found it very useful to be able to pause the recordings, look up references and reflect on learning. It also helps you consolidate learning to share with your team. (See further feedback below)
Lecture recordings are available to all delegates who attended the live study day, as part of their supporting educational resources.
CPD: 5 credits
Dr Mary Miller and Dr Matt Carey (Chairs)
Feedback in 2023 - thank you!
"Extremely interesting. So much change - really helpful. Should be mandatory for palliative care doctors!"
"Excellent range of speakers"
"Excellent oncology update today. Great resources available with references and guidelines"
"I love this Zoom format and will be back for more next year!"
Feedback in 2024 - Word cloud
Location: Virtual - Recorded
Educational Credits: 5 Credits
+ Venue
Virtual educational event
+ Speakers
Chairs: Dr Matt Carey & Dr Mary Miller
Confirmed speakers:
1. Genitourinary cancers: Dr Joao Barata, Consultant Oncologist, Oxford University Hospitals
2. Cancer Unknown Primary origin: Dr Elizabeth Smyth, Consultant Oncologist, Oxford University Hospitals
3. Haematological malignancies, stem cell transplants and CAR T-cell therapy. Dr Jennifer Vidrine, Consultant palliative medicine, Northern Centre for cancer care, Newcastle upon Tyne,
4. Advances in Immunotherapies & Targeted therapies - treatments and toxicities Dr Anna Olsson-Brown, Consultant Clinical Oncologist at the Royal Sussex County Hospital
Programme development in progress for 2024 - we want the 10th anniversary to be a special event.
+ Course Programmes
(timings TBC)
08.50 welcome
09.00 Advances in Immunotherapies & Targeted therapies - treatments and toxicities
10.00 Break
10.10 Genito-urinary cancers
11.10 Break
11.30 Cancer of Unknown Primary Origin
12.30 Haematological malignancies, stem cell transplants and CAR T-cell therapy
13.30 Break
13.40 Evidence update
14.25 Q&A
14.40 Close
+ Course Aims
Following the study day participants will:
- Have gained a deeper understanding of the current management of the tumour sites considered
- Be able to use the knowledge gained to help with the management of patients
- Be able to use new knowledge to aid in prognostication
- Have had an opportunity to ask questions and engage with the speakers to enable the translation of knowledge into practice
